bulletinhistoryconnectmaincategories
missionhelpchatblogs

ProKidney Announces Q3 2025 Financial Outcomes and Key Developments

November 11, 2025 - 01:05

ProKidney Announces Q3 2025 Financial Outcomes and Key Developments

ProKidney has released its financial results for the third quarter of 2025, highlighting significant progress in its clinical studies and regulatory endeavors. The company recently showcased full results from the Phase 2 REGEN-007 study of rilparencel during a late-breaking clinical trial session at the American Society of Nephrology (ASN) Kidney Week 2025. This presentation underscores the promising developments in their research efforts.

As part of their ongoing commitment to advancing kidney disease treatment, ProKidney has successfully enrolled more than half of the patients needed for the Phase 3 REGEN-006 (PROACT 1) accelerated approval analysis, which focuses on the estimated glomerular filtration rate (eGFR) slope. The company anticipates topline results from this study to be available in the second quarter of 2027, marking a critical milestone in their clinical timeline.

Financially, ProKidney concluded the third quarter with a robust position, holding $272 million in cash, cash equivalents, and marketable securities. This financial strength positions the company well for future growth and innovation in the healthcare sector.


MORE NEWS

Making Cents: Financial expert shares everyday habit to rethink

April 7, 2026 - 00:24

Making Cents: Financial expert shares everyday habit to rethink

A leading financial expert is urging consumers to critically examine one of their most routine money habits: the use of digital payment apps and cards for daily, small purchases. While convenient,...

A Generational Investment Opportunity: 3 AI Stocks I'm Buying Now

April 6, 2026 - 02:35

A Generational Investment Opportunity: 3 AI Stocks I'm Buying Now

The recent market volatility has created a compelling entry point for investors looking to build a position in the transformative field of artificial intelligence. Several industry-leading...

Isa savers under 65 have ‘last chance’ in the new 2026-27 tax year

April 5, 2026 - 01:23

Isa savers under 65 have ‘last chance’ in the new 2026-27 tax year

The approaching 2026-27 tax year represents a pivotal deadline for many UK savers. Individuals under the age of 65 are being alerted to a final chance to fully utilise the current annual Cash ISA...

Copper-Aluminum Divergence Unveils The Complex Iran War Impact

April 4, 2026 - 17:14

Copper-Aluminum Divergence Unveils The Complex Iran War Impact

Four weeks into the ongoing Middle East conflict, a significant divergence has emerged between two key industrial metals: copper and aluminum. While both are sensitive to global economic sentiment,...

read all news
bulletinhistoryconnectmaincategories

Copyright © 2026 Coinlyt.com

Founded by: Eric McGuffey

missionhelpchatpicksblogs
data policycookiesterms of use